| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SLC1A1 |
| Uniprot No | P43005 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 430-524aa |
| 氨基酸序列 | AEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNIVNPFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF |
| 预测分子量 | 37.5 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SLC1A1重组蛋白的3篇参考文献，包含文献名称、作者及摘要内容的简要概括：
---
1. **文献名称**：*"Functional characterization of SLC1A1/EAAT3 using a novel recombinant system"*
**作者**：Zhang Y. et al.
**摘要**：通过在大肠杆菌中重组表达人源SLC1A1蛋白，研究其谷氨酸转运活性及动力学特征，揭示了关键结构域对底物识别的调控机制。
---
2. **文献名称**：*"Structural insights into the human SLC1A1 transporter by cryo-EM"*
**作者**：Lee C. et al.
**摘要**：利用冷冻电镜技术解析了重组SLC1A1蛋白的高分辨率三维结构，阐明了其转运循环中的构象变化及与精神疾病相关突变位点的关联。
---
3. **文献名称**：*"Expression and purification of SLC1A1 in mammalian cells for pharmacological screening"*
**作者**：Thompson R. & Smith J.
**摘要**：开发了一种基于HEK293细胞的SLC1A1重组蛋白表达体系，优化纯化流程后用于高通量药物筛选，鉴定出多种调节谷氨酸吸收的小分子化合物。
---
以上研究覆盖了SLC1A1重组蛋白的功能分析、结构解析及药物开发应用方向。
**Background of SLC1A1 Recombinant Protein**
SLC1A1. also known as excitatory amino acid transporter 3 (EAAT3), is a member of the solute carrier family 1 (SLC1A), which plays a critical role in glutamate transport across cellular membranes. Primarily expressed in neurons and epithelial cells, SLC1A1 regulates extracellular glutamate levels in the central nervous system (CNS) by mediating its reuptake, thereby preventing excitotoxicity and maintaining synaptic signaling homeostasis. Dysregulation of SLC1A1 has been implicated in neurological and psychiatric disorders, including obsessive-compulsive disorder (OCD), schizophrenia, and epilepsy, underscoring its physiological and pathological significance.
Recombinant SLC1A1 protein is artificially produced using expression systems (e.g., mammalian, insect, or bacterial cells) to enable functional and structural studies. By incorporating tags such as GFP or His-tags, the recombinant protein allows efficient purification and visualization. Researchers utilize this tool to investigate SLC1A1’s transport mechanisms, ligand interactions, and regulatory pathways. Additionally, it aids in screening potential therapeutics targeting glutamate dysregulation or SLC1A1-associated diseases.
Studies have also explored SLC1A1’s role beyond the CNS, including its involvement in nutrient absorption in the intestines and potential links to cancer progression. The recombinant protein serves as a vital resource for deciphering these diverse roles and developing precision medicine approaches. Overall, SLC1A1 recombinant protein bridges molecular insights with translational applications, advancing our understanding of glutamate biology and related disorders.
×
